• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SLC22A12 基因与痛风易感性的关联:一项荟萃分析。

Associations between the SLC22A12 gene and gout susceptibility: a meta-analysis.

机构信息

Department of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, China.

出版信息

Clin Exp Rheumatol. 2018 May-Jun;36(3):442-447. Epub 2018 Jan 15.

PMID:29352852
Abstract

OBJECTIVES

The aim of this study is to explore whether the polymorphisms of rs475688 and rs3825016 in the solute carrier family 22 member 12 (SLC22A12) gene are associated with the susceptibility to gout or hyperuricaemia.

METHODS

Relevant studies were enrolled by searching databases systematically. The pooled odds ratios (ORs) with 95% confidence interval (CI) were used to evaluate the associations. Q-test and I2 statistics were used to evaluate the heterogeneity. Publication bias was evaluated using Begg's funnel plots and Egger regression test.

RESULTS

A total of 7 articles involving 1216 patients and 1844 healthy controls were included in this meta-analysis. Significant association was detected between rs475688 polymorphism and gout susceptibility in three genetic models (C vs. T: OR=1.464, 95% CI 1.078-1.989, p=0.015; CC+CT vs. TT: OR=2.028, 95% CI 1.488-2.763, p=0.000; CC vs. CT+TT: OR=2.226, 95% CI 1.746-2.838, p=0.000). Significant association was observed between rs3825016 polymorphism and hyperuricaemia susceptibility only in allelic comparison (C vs. T: OR=1.274, 95% CI 1.101-1.474, p=0.001).

CONCLUSIONS

The rs475688 polymorphism is associated with gout susceptibility. The correlation between rs3825016 polymorphism of SLC22A12 and hyperuricaemia susceptibility is possible.

摘要

目的

本研究旨在探讨溶质载体家族 22 成员 12(SLC22A12)基因中的 rs475688 和 rs3825016 多态性是否与痛风或高尿酸血症易感性相关。

方法

通过系统检索数据库,纳入相关研究。采用合并优势比(OR)及其 95%置信区间(CI)评估相关性。采用 Q 检验和 I² 统计量评估异质性。采用 Begg 漏斗图和 Egger 回归检验评估发表偏倚。

结果

本荟萃分析共纳入 7 项研究,包括 1216 例患者和 1844 例健康对照。在三种遗传模型中,rs475688 多态性与痛风易感性显著相关(C 与 T 相比:OR=1.464,95%CI 1.078-1.989,p=0.015;CC+CT 与 TT 相比:OR=2.028,95%CI 1.488-2.763,p=0.000;CC 与 CT+TT 相比:OR=2.226,95%CI 1.746-2.838,p=0.000)。仅在等位基因比较中,rs3825016 多态性与高尿酸血症易感性显著相关(C 与 T 相比:OR=1.274,95%CI 1.101-1.474,p=0.001)。

结论

rs475688 多态性与痛风易感性相关。SLC22A12 基因的 rs3825016 多态性与高尿酸血症易感性可能相关。

相似文献

1
Associations between the SLC22A12 gene and gout susceptibility: a meta-analysis.SLC22A12 基因与痛风易感性的关联:一项荟萃分析。
Clin Exp Rheumatol. 2018 May-Jun;36(3):442-447. Epub 2018 Jan 15.
2
Genetic Association Between Variants and Susceptibility to Hyperuricemia: A Meta-Analysis.遗传变异与高尿酸血症易感性的关联:荟萃分析。
Genet Test Mol Biomarkers. 2022 Feb;26(2):81-95. doi: 10.1089/gtmb.2021.0175.
3
URAT1 inhibition by ALPK1 is associated with uric acid homeostasis.ALPK1对URAT1的抑制作用与尿酸稳态相关。
Rheumatology (Oxford). 2017 Apr 1;56(4):654-659. doi: 10.1093/rheumatology/kew463.
4
Polymorphisms of and Genes Associated with Gout Risk in Vietnamese Population.越南人群中与痛风风险相关的 和 基因多态性
Medicina (Kaunas). 2019 Jan 7;55(1):8. doi: 10.3390/medicina55010008.
5
Variants of ALPK1 with ABCG2, SLC2A9, and SLC22A12 increased the positive predictive value for gout.携带 ALPK1 变异的个体与 ABCG2、SLC2A9 和 SLC22A12 共同增加了痛风的阳性预测值。
J Hum Genet. 2018 Jan;63(1):63-70. doi: 10.1038/s10038-017-0368-9. Epub 2017 Nov 8.
6
Additive composite ABCG2, SLC2A9 and SLC22A12 scores of high-risk alleles with alcohol use modulate gout risk.高风险等位基因与饮酒的相加性复合ABCG2、SLC2A9和SLC22A12评分可调节痛风风险。
J Hum Genet. 2016 Sep;61(9):803-10. doi: 10.1038/jhg.2016.57. Epub 2016 May 26.
7
High-resolution melting analysis for the rapid detection of an intronic single nucleotide polymorphism in SLC22A12 in male patients with primary gout in China.中国男性原发性痛风患者 SLC22A12 内含子单核苷酸多态性的快速检测——高分辨率熔解曲线分析
Scand J Rheumatol. 2009;38(4):276-81. doi: 10.1080/03009740802572483.
8
Association between SLC2A9 (GLUT9) gene polymorphisms and gout susceptibility: an updated meta-analysis.SLC2A9(GLUT9)基因多态性与痛风易感性的关联:一项更新的荟萃分析。
Rheumatol Int. 2016 Aug;36(8):1157-65. doi: 10.1007/s00296-016-3503-6. Epub 2016 Jun 2.
9
Absence of the SLC22A12 gene mutation in Turkish population with primary gout disease.土耳其原发性痛风病患者中不存在 SLC22A12 基因突变。
Rheumatol Int. 2013 Nov;33(11):2921-5. doi: 10.1007/s00296-012-2533-y. Epub 2012 Nov 6.
10
The hURAT1 rs559946 polymorphism and the incidence of gout in Han Chinese men.hURAT1 rs559946 多态性与汉族男性痛风的发病风险。
Scand J Rheumatol. 2014;43(1):35-42. doi: 10.3109/03009742.2013.808375. Epub 2013 Aug 28.

引用本文的文献

1
Enrichment analysis and chromosomal distribution of gout susceptible loci identified by genome-wide association studies.全基因组关联研究鉴定出的痛风易感位点的富集分析及染色体分布
EXCLI J. 2023 Nov 14;22:1146-1154. doi: 10.17179/excli2023-6481. eCollection 2023.
2
Research progress of risk factors and early diagnostic biomarkers of gout-induced renal injury.痛风相关性肾损伤的危险因素及早期诊断生物标志物的研究进展。
Front Immunol. 2022 Sep 20;13:908517. doi: 10.3389/fimmu.2022.908517. eCollection 2022.
3
Differential gene expression of ABCG2, SLC22A12, IL-1β, and ALPK1 in peripheral blood leukocytes of primary gout patients with hyperuricemia and their comorbidities: a case-control study.
原发性痛风伴高尿酸血症患者及其合并症外周血白细胞 ABCG2、SLC22A12、IL-1β 和 ALPK1 的差异基因表达:病例对照研究。
Eur J Med Res. 2022 May 3;27(1):62. doi: 10.1186/s40001-022-00684-1.
4
Urate Transporters in the Kidney: What Clinicians Need to Know.肾脏中的尿酸转运体:临床医生需要了解的内容。
Electrolyte Blood Press. 2021 Jun;19(1):1-9. doi: 10.5049/EBP.2021.19.1.1. Epub 2021 Jun 30.
5
Update on the epidemiology, genetics, and therapeutic options of hyperuricemia.高尿酸血症的流行病学、遗传学及治疗选择的最新进展
Am J Transl Res. 2020 Jul 15;12(7):3167-3181. eCollection 2020.
6
Evaluation of the Influence of Genetic Variants of (GLUT9) and (URAT1) on the Development of Hyperuricemia and Gout.评估葡萄糖转运蛋白9(GLUT9)和尿酸转运蛋白1(URAT1)基因变异对高尿酸血症和痛风发生发展的影响。
J Clin Med. 2020 Aug 4;9(8):2510. doi: 10.3390/jcm9082510.